FDA Adverse Event
Death
Summary report: N
MUGARD
MDR report key: 19905796
·
Received August 2, 2024
Report
- Report Number
- MW5157969
- Event Type
- Death
- Date Received
- August 2, 2024
- Report Date
- July 31, 2024
- Manufacturer
- SOLEVA PHARMA LLC
- Product Code
- MGQ
- Adverse Event
- Yes
- Report Source
- Voluntary report
- Reporter Location
- PA, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
ADDITIONAL INFORMATION RECEIVED ON 8/7/2024 FOR REPORT MW5157969 TO UPDATE THE MANUFACTURER TO SOLEVA PHARMA LLC.
Description of Event or Problem · 0
THE PATIENT'S SON, (B)(6), REPORTED THAT THE PATIENT PASSED AWAY ON (B)(6) 2024. NO ADDITIONAL DETAILS DOCUMENTED. THE FOLLOWING PRODUCT INFORMATION REFLECTS THE LAST DISPENSE BY (B)(6) PHARMACY (DELIVERED (B)(6) 2024) AND WAS NOT PROVIDED BY THE PRIMARY REPORTER. MALIGNANT NEOPLASM OF BODY OF PANCREAS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2273765 | MUGARD | DRESSING, WOUND AND BURN, HYDROGEL W/DRUG AND/OR BIOLOGIC | MGQ | SOLEVA PHARMA LLC | MV1040 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Female | Death | SYNTHROID |